WATSON PHARMACEUTICALS INC·4

Aug 24, 4:56 PM ET

FELDMAN MICHEL J 4

4 · WATSON PHARMACEUTICALS INC · Filed Aug 24, 2010

Insider Transaction Report

Form 4
Period: 2010-08-23
Transactions
  • Sale

    Common Stock, par value $0.0033

    2010-08-23$42.48/sh8,334$354,01210,000 total
Holdings
  • Common Stock, par value $0.0033

    (indirect: By Spouse)
    1,000
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.46 to $42.51, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
  • [F2]Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -